arsenic trioxide has been researched along with Kidney Failure, Chronic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Firkin, F; Ho, WK; Roncolato, F | 1 |
| Eyler, R; Moeller, J; Patel, K; Perreault, S; Pham, T; Podoltsev, N; Russell, K | 1 |
| Chun, HJ; Chung, BH; Kim, JI; Kim, SJ; Min, WS; Moon, IS; Sun, IO; Yang, CW | 1 |
3 other study(ies) available for arsenic trioxide and Kidney Failure, Chronic
| Article | Year |
|---|---|
Dose-adjusted arsenic trioxide for acute promyelocytic leukaemia in chronic renal failure.
Topics: Adult; Aged; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Drug Monitoring; Female; Humans; Kidney Failure, Chronic; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Oxides; Pilot Projects; Treatment Outcome | 2015 |
Use of arsenic trioxide in a hemodialysis-dependent patient with relapsed acute promyelocytic leukemia.
Topics: Aged, 80 and over; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Drug Monitoring; Humans; Kidney Failure, Chronic; Leukemia, Promyelocytic, Acute; Male; Oxides; Renal Dialysis | 2016 |
Kidney transplantation in a patient with end stage renal disease after complete remission of acute promyelocytic leukemia.
Topics: Adult; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Bone Marrow Cells; Humans; Kidney Failure, Chronic; Kidney Transplantation; Leukemia, Promyelocytic, Acute; Male; Oxides; Receptors, Retinoic Acid; Remission Induction; Retinoic Acid Receptor alpha; Ultrasonography | 2012 |